ACR Journals On Air Opioids and SARDs
Nov 26, 2024
Inan Huang, an assistant professor of pharmacy administration and a research expert in rheumatology, discusses a pivotal study on opioid treatment trends for adults with systemic autoimmune and inflammatory rheumatic diseases. The conversation reveals how patients with conditions like rheumatoid arthritis face different challenges compared to the general population regarding opioid effectiveness and safety. Huang also addresses critical insights from the National Ambulatory Medical Care Survey, shedding light on disparities in prescribing practices and the urgent need for more research on long-term opioid use in these patients.
AI Snips
Chapters
Transcript
Episode notes
Pain and Opioid Use in SARDs
- People with SARDs experience pain due to inflammation and central pain processing issues.
- Opioid effectiveness for chronic non-cancer pain, like in SARDs, has limited evidence, while risks like hospitalization and fractures increase.
NAMCS Data Collection
- The NAMCS survey uses a three-stage probability sampling design to collect data from non-federal office-based physicians and community health centers.
- It gathers patient and physician characteristics, healthcare services, and medication usage data.
Study Population
- The study included adults with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and lupus.
- Pediatric patients and those without SARDs served as control groups for comparison.